Source comparison
TB-500 Research Diet Considerations: Nutrient Comparison
Post-administration protein 25–40g complete protein within 90 minutes No strategic timing or delayed intake Amino acid substrate availability for actin polymerization and collagen synthesis Critical for peptide efficacy. Substrate depletion limits tissue repai
This comparison does not assign a generated winner or score.
- Post-administration protein
- 25–40g complete protein within 90 minutes
- No strategic timing or delayed intake
- Amino acid substrate availability for actin polymerization and collagen synthesis
- Critical for peptide efficacy. Substrate depletion limits tissue repair signaling regardless of TB-500 dose
- Omega-6 intake
- <4% total calories, eliminate seed oils
- >8% calories from linoleic acid sources
- Arachidonic acid metabolites drive inflammatory cytokine expression that sequesters peptides
- Inflammatory cascade competes directly with tissue repair pathways. Uncontrolled omega-6 intake undermines peptide bioavailability
- Omega-3 supplementation
- 2–3g combined EPA/DHA daily from marine sources
- <1g daily or inconsistent intake
- NF-kB suppression and reduced pro-inflammatory cytokine expression
- Foundation requirement, not optional. Insufficient omega-3 leaves inflammatory signaling unopposed
- Hydration volume
- 40–45 ml/kg body weight on administration days
- <30 ml/kg or sporadic intake
- Interstitial fluid dynamics and lymphatic peptide distribution
- Dehydration localizes peptide at injection depot. Systemic distribution requires adequate interstitial fluid volume
- Sodium intake
- 3,000–4,000 mg daily during protocols
- <2,000 mg or excessive restriction
- Water retention in interstitial spaces where peptides diffuse
- Low-sodium protocols impair subcutaneous distribution. Peptide remains at depot rather than entering systemic circulation
- Anti-inflammatory compounds
- Curcumin 500mg + piperine 20mg, quercetin 500mg daily
- Sporadic or absent supplementation
- COX-2 and lipoxygenase pathway inhibition
- Competing inflammatory cascades divert peptide signaling. Targeted inhibition keeps TB-500 pathways dominant